Google Play icon

Two mood drugs combat virus implicated in birth defects

Posted September 21, 2016

Two mood-stabilizing drugs provide protection against a potentially dangerous virus implicated in birth defects as well as disease in people with compromised immune systems, Yale School of Medicine researchers have found.

Cells (green) infected by cytomegalovirus.

Cells (green) infected by cytomegalovirus.

The related drugs, valnoctamide and valpromide, are approved for treatment of neurologic and psychiatric brain disorders such as epilepsy and bipolar disorder; both inhibit cytomegalovirus (CMV), one of the major causes of birth defects in infected fetuses, the researchers report Sept. 21 in the journal Virology.

“It is our hope that these existing drugs might ultimately help limit damage of fetal CMV infection, for which there is no treatment,” said Anthony van den Pol, professor of neurosurgery at Yale and senior author of the paper.

Survival rates and overall health of mice infected with CMV improved dramatically when the drugs were administered, the researchers report.  Also, the virus was inhibited in human cells infected with CMV.

Congenital CMV is the major infectious cause of birth defects and neuro-developmental disabilities, including microcephaly, hearing loss, blindness, and mental retardation.

Sara Ornaghi is the lead author of the paper and primary funding for the research came from the National Institutes of Health.

Source: Yale University

Featured news from related categories:

Technology Org App
Google Play icon
85,339 science & technology articles

Most Popular Articles

  1. New treatment may reverse celiac disease (October 22, 2019)
  2. "Helical Engine" Proposed by NASA Engineer could Reach 99% the Speed of Light. But could it, really? (October 17, 2019)
  3. New Class of Painkillers Offers all the Benefits of Opioids, Minus the Side Effects and Addictiveness (October 16, 2019)
  4. The World's Energy Storage Powerhouse (November 1, 2019)
  5. Plastic waste may be headed for the microwave (October 18, 2019)

Follow us

Facebook   Twitter   Pinterest   Tumblr   RSS   Newsletter via Email